Last month, Evotec entered into a multi-year collaboration deal with Pfizer PFE. Per the deal terms, this partnership with ...

Looking at Pfizer's recent performance in business turnaround, I think the recovery in PFE stock should continue in the medium term - the 10% total return since June 2024 may be just the beginning ...

Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The ...

Aug 27 (Reuters) - Pfizer Inc (PFE.N), opens new tab is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses. The drugmaker ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Cutting out middleman and selling drugs straight to patients. The company launched ...

The Food and Drug Administration announced Thursday it has greenlighted updated COVID-19 vaccines from Pfizer and Moderna for the 2024 fall season. The decision clears the way for distribution to ...

Pfizer (NYSE:PFE) has announced PfizerForAll, a new website that will offer vaccines, medical tests and medications delivered at home. PfizerForAll is designed for patients with migraine, COVID-19 ...

To start, according to Pfizer’s launch announcement Tuesday, the platform’s services will focus on providing access to treatments for common conditions like migraine, COVID-19 and the flu as ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...

Pharma giant's new portal aims to connect consumers with telehealth appointments, prescription delivery, tests and vaccines Pfizer Inc. on Tuesday unveiled a new online platform designed to help ...

The Food and Drug Administration has greenlighted three updated vaccines — the Pfizer-BioNTech and Moderna shots, and now a third one from Novavax, which was just authorized by the FDA on Friday.

Following several years of legal back-and-forth, AMAG Pharmaceuticals has lost its bid to claim insurance coverage for a manufacturing snafu that took place at a Pfizer facility back in 2017.